This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Laevosan-Gesellschaft Gmbh. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Josef Peter Guggenbichler: Innovator in Pharmaceutical Preparations
Introduction
Josef Peter Guggenbichler is a notable inventor based in Furth, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of preparations that inhibit the attachment of germs to human cells. His innovative work has the potential to impact healthcare positively.
Latest Patents
Guggenbichler holds a patent for a pharmaceutical preparation that contains one or several galacturonides as the active substance. This preparation is designed to block the attachment of germs to mammalian cells. The invention is characterized by a degree of polymerization of ≥2 and a degree of esterification of <20%. This groundbreaking work is crucial in the fight against infections and enhances the efficacy of pharmaceutical treatments.
Career Highlights
Throughout his career, Guggenbichler has been associated with Laevosan-Gesellschaft GmbH, where he has furthered his research and development efforts. His dedication to innovation in pharmaceuticals has established him as a respected figure in the industry.
Collaborations
Guggenbichler has worked alongside notable colleagues such as Peter Meissner and Johann Jurenitsch. Their collaborative efforts have contributed to advancements in pharmaceutical science and the development of effective treatments.
Conclusion
Josef Peter Guggenbichler's work in pharmaceutical preparations exemplifies the impact of innovation in healthcare. His patent for blocking germ attachment is a testament to his commitment to improving human health through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile